SG11202003049WA - Prodrugs of substituted triazole derivatives and uses thereof - Google Patents

Prodrugs of substituted triazole derivatives and uses thereof

Info

Publication number
SG11202003049WA
SG11202003049WA SG11202003049WA SG11202003049WA SG11202003049WA SG 11202003049W A SG11202003049W A SG 11202003049WA SG 11202003049W A SG11202003049W A SG 11202003049WA SG 11202003049W A SG11202003049W A SG 11202003049WA SG 11202003049W A SG11202003049W A SG 11202003049WA
Authority
SG
Singapore
Prior art keywords
prodrugs
triazole derivatives
substituted triazole
substituted
derivatives
Prior art date
Application number
SG11202003049WA
Inventor
Marie-Pierre Collin-Kroepelin
Peter Kolkhof
Thomas Neubauer
Chantal Fuerstner
Elisabeth Pook
Matthias Wittwer
Carsten Schmeck
Pierre Wasnaire
Heiko Schirmer
Hana Cernecka
Karoline Droebner
Hanna Tinel
Anja Buchmueller
Thomas Mondritzki
Axel Kretschmer
Klemens Lustig
Robert Fricke
Guillaume Levilain
Ursula Krenz
Norbert Witowski
Original Assignee
Bayer Ag
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Bayer Pharma AG filed Critical Bayer Ag
Publication of SG11202003049WA publication Critical patent/SG11202003049WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
SG11202003049WA 2017-10-24 2018-10-17 Prodrugs of substituted triazole derivatives and uses thereof SG11202003049WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17197935 2017-10-24
PCT/EP2018/078364 WO2019081292A1 (en) 2017-10-24 2018-10-17 Prodrugs of substituted triazole derivatives and uses thereof

Publications (1)

Publication Number Publication Date
SG11202003049WA true SG11202003049WA (en) 2020-04-29

Family

ID=60162099

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003049WA SG11202003049WA (en) 2017-10-24 2018-10-17 Prodrugs of substituted triazole derivatives and uses thereof

Country Status (38)

Country Link
US (1) US11298367B2 (en)
EP (1) EP3700913B1 (en)
JP (1) JP2021500365A (en)
KR (1) KR20200069361A (en)
CN (1) CN111225921A (en)
AR (1) AR113791A1 (en)
AU (1) AU2018356352A1 (en)
BR (1) BR112020007983A2 (en)
CA (1) CA3079767A1 (en)
CL (1) CL2020001076A1 (en)
CO (1) CO2020004945A2 (en)
CR (1) CR20200176A (en)
CU (1) CU24604B1 (en)
CY (1) CY1124938T1 (en)
DK (1) DK3700913T3 (en)
DO (1) DOP2020000076A (en)
EA (1) EA202091025A1 (en)
EC (1) ECSP20023056A (en)
ES (1) ES2906305T3 (en)
HR (1) HRP20220060T1 (en)
HU (1) HUE057278T2 (en)
IL (1) IL273949A (en)
JO (1) JOP20200099A1 (en)
LT (1) LT3700913T (en)
MA (1) MA50438B1 (en)
MX (1) MX2020004191A (en)
NI (1) NI202000030A (en)
PE (1) PE20210394A1 (en)
PH (1) PH12020550473A1 (en)
PL (1) PL3700913T3 (en)
PT (1) PT3700913T (en)
RS (1) RS62984B1 (en)
SG (1) SG11202003049WA (en)
SI (1) SI3700913T1 (en)
TW (1) TW201932117A (en)
UA (1) UA126456C2 (en)
UY (1) UY37948A (en)
WO (1) WO2019081292A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021259852A1 (en) 2020-06-25 2021-12-30 Bayer Aktiengesellschaft Process for preparing 5-(alkoxycarbonyl)-and 5-(carboxamide)-1-aryl-1,2,4-triazole derivatives
WO2022112213A1 (en) 2020-11-30 2022-06-02 Bayer Aktiengesellschaft Crystalline forms of 3-[[3-(4-chlorophenyl)-5-oxo-4-((2s)-3,3,3-trifluoro- 2-hydroxypropyl)-4,5-dihydro-1h-1,2,4-triazol-1-yl]methyl]-1-[3- (trifluoromethyl)pyridin-2-yl]-1h-1,2,4-triazole-5-carboxamide

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966781A (en) 1970-12-17 1976-06-29 Merck Sharp & Dohme (I.A.) Corporation Deuteration of functional group-containing hydrocarbons
DE19834044A1 (en) 1998-07-29 2000-02-03 Bayer Ag New substituted pyrazole derivatives
DE19834047A1 (en) 1998-07-29 2000-02-03 Bayer Ag Substituted pyrazole derivatives
DE19943635A1 (en) 1999-09-13 2001-03-15 Bayer Ag Novel aminodicarboxylic acid derivatives with pharmaceutical properties
DE19943639A1 (en) 1999-09-13 2001-03-15 Bayer Ag Dicarboxylic acid derivatives with novel pharmaceutical properties
DE19943636A1 (en) 1999-09-13 2001-03-15 Bayer Ag Novel dicarboxylic acid derivatives with pharmaceutical properties
DE19943634A1 (en) 1999-09-13 2001-04-12 Bayer Ag Novel dicarboxylic acid derivatives with pharmaceutical properties
AR031176A1 (en) 2000-11-22 2003-09-10 Bayer Ag NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE
DE10110750A1 (en) 2001-03-07 2002-09-12 Bayer Ag Novel aminodicarboxylic acid derivatives with pharmaceutical properties
DE10110749A1 (en) 2001-03-07 2002-09-12 Bayer Ag Substituted aminodicarboxylic acid derivatives
DE10220570A1 (en) 2002-05-08 2003-11-20 Bayer Ag Carbamate-substituted pyrazolopyridines
KR100854872B1 (en) 2003-12-22 2008-08-28 화이자 인코포레이티드 Triazole derivatives as vasopressin antagonists
WO2005105779A1 (en) 2004-04-28 2005-11-10 Pfizer Limited 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
JP2011502982A (en) * 2007-11-06 2011-01-27 アストラゼネカ・アクチエボラーグ Certain 2-pyrazinone derivatives and their use as inhibitors of neutrophil elastase
DE102010001064A1 (en) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
AR076542A1 (en) * 2009-05-22 2011-06-22 Merck Sharp & Dohme ISONICOTINAMIDE OREXINE RECEIVER ANTAGONISTS
AU2011219746B2 (en) 2010-02-27 2015-04-23 Bayer Intellectual Property Gmbh Bisaryl-bonded aryltriazolones and use thereof
DE102010021637A1 (en) 2010-05-26 2011-12-01 Bayer Schering Pharma Aktiengesellschaft Substituted 5-fluoro-1H-pyrazolopyridines and their use
CN106977530A (en) 2010-07-09 2017-07-25 拜耳知识产权有限责任公司 Ring fusion pyrimidine and triazine and its be used for treat and/or prevention of cardiovascular disease purposes
DE102010040233A1 (en) 2010-09-03 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Bicyclic aza heterocycles and their use
DE102010043379A1 (en) 2010-11-04 2012-05-10 Bayer Schering Pharma Aktiengesellschaft Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
US8791162B2 (en) 2011-02-14 2014-07-29 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
MX2016004532A (en) * 2013-10-16 2016-07-22 Bayer Cropscience Ag Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound.
CN107074783B (en) 2014-11-03 2020-06-05 拜耳制药股份公司 Hydroxyalkyl substituted phenyl triazole derivatives and uses thereof
UY36571A (en) * 2015-03-05 2016-09-30 Bayer Cropscience Ag COMBINATIONS OF ACTIVE COMPOUNDS
AR108265A1 (en) 2016-05-03 2018-08-01 Bayer Pharma AG FENILTRIAZOL DERIVATIVES REPLACED WITH AMIDA AND USES OF THESE
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof
WO2017191114A1 (en) 2016-05-03 2017-11-09 Bayer Aktiengesellschaft Hydroxyalkyl-substituted heteroaryltriazole derivatives and uses thereof
WO2017191105A1 (en) 2016-05-03 2017-11-09 Bayer Pharma Aktiengesellschaft Amide-substituted aryltriazole derivatives and uses thereof
EP3452457B1 (en) 2016-05-03 2020-03-18 Bayer Pharma Aktiengesellschaft Oxoalkyl-substituted phenyltriazole derivatives and uses thereof
US10525041B2 (en) 2016-05-03 2020-01-07 Bayer Pharma Aktiengesellschaft Fluoroalkyl-substituted aryltriazole derivatives and uses thereof
WO2018073144A1 (en) 2016-10-20 2018-04-26 Bayer Pharma Aktiengesellschaft Hydroxyalkyl-substituted triazole derivatives and uses thereof

Also Published As

Publication number Publication date
EP3700913B1 (en) 2021-11-10
CN111225921A (en) 2020-06-02
CU20200040A7 (en) 2021-03-11
DK3700913T3 (en) 2022-02-07
LT3700913T (en) 2022-01-25
JP2021500365A (en) 2021-01-07
PE20210394A1 (en) 2021-03-02
UA126456C2 (en) 2022-10-05
AU2018356352A1 (en) 2020-04-16
MA50438A (en) 2020-09-02
ES2906305T3 (en) 2022-04-18
MX2020004191A (en) 2020-08-03
WO2019081292A1 (en) 2019-05-02
UY37948A (en) 2019-05-31
BR112020007983A2 (en) 2020-10-27
AR113791A1 (en) 2020-06-10
US20200338096A1 (en) 2020-10-29
CO2020004945A2 (en) 2020-05-05
PL3700913T3 (en) 2022-02-21
PH12020550473A1 (en) 2021-03-08
PT3700913T (en) 2022-01-31
US11298367B2 (en) 2022-04-12
NI202000030A (en) 2020-10-09
CR20200176A (en) 2020-07-24
SI3700913T1 (en) 2022-02-28
CL2020001076A1 (en) 2021-02-19
CA3079767A1 (en) 2019-05-02
DOP2020000076A (en) 2020-08-31
TW201932117A (en) 2019-08-16
HRP20220060T1 (en) 2022-04-15
CU24604B1 (en) 2022-06-06
EA202091025A1 (en) 2020-07-30
RS62984B1 (en) 2022-03-31
IL273949A (en) 2020-05-31
ECSP20023056A (en) 2020-12-31
HUE057278T2 (en) 2022-04-28
MA50438B1 (en) 2022-03-31
JOP20200099A1 (en) 2020-05-06
EP3700913A1 (en) 2020-09-02
CY1124938T1 (en) 2023-01-05
KR20200069361A (en) 2020-06-16

Similar Documents

Publication Publication Date Title
IL272888A (en) Novel uses of piperidinyl-indole derivatives
SG11201706729SA (en) Derivatives of sobetirome
IL273440A (en) Potentiating the effect of atp release
IL263050B (en) Derivatives of sobetirome
IL269409A (en) Combinations of chk1- and wee1 - inhibitors
IL274627A (en) Solid state form of valbenazine
IL276592A (en) Derivatives of sobetirome
GB201708457D0 (en) Inhibitors of metallo-beta-lactamases
IL272857A (en) Formulations of copanlisib
IL273949A (en) Prodrugs of substituted triazole derivatives and uses thereof
EP3407885A4 (en) Triazole derivatives of melampomagnolide b and methods of use thereof
IL270703B1 (en) Derivatives of resiquimod
EP3654987A4 (en) Use of aminoalkylbenzothiazepine derivatives
EP3721889A4 (en) Use of butyribacter intestini
GB201708451D0 (en) Inhibitors of metallo-beta-lactamases
PT3678644T (en) Formulations of copanlisib
GB201721841D0 (en) Set of headphones
ZA201908264B (en) Formulations of homotaurines and salts thereof
GB201721386D0 (en) Chrondogy of time-wave
PL422741A1 (en) New derivatives of 5-aminotetrazole with antibacterial and antimycotic effects
AU2017901956A0 (en) Inhibition of ferroptosis
AU2017904670A0 (en) Improvement of clothes-hangers
HUE048323T2 (en) Substituted pyrazolyl-pyrazole derivative and use of same as herbicide
AU2015900377A0 (en) Methods for the inhibition and dispersal of biofilms